Indomethacin has proven effective in closing the patent ductus arteriosus (PDA) in most low birth weight (LBW) neonates with this disorder. Early reopening of the ductus is a problem and often leads to the need for surgery. Prolonged use of indomethacin for several days has been suggested as a means
โฆ LIBER โฆ
Hydrocortisone for refractory hypotension of very low birth weight infant with patent ductus arteriosus: a case report
โ Scribed by Hyun Young Lee; Sang Hun Kim; Ki Tae Jung; Keum young So
- Publisher
- Springer
- Year
- 2011
- Tongue
- English
- Weight
- 116 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0913-8668
No coin nor oath required. For personal study only.
๐ SIMILAR VOLUMES
Effects of prolonged versus acute indome
โ
P. G. Rhodes; M. G. Ferguson; N. S. Reddy; J. A. Joransen; J. Gibson
๐
Article
๐
1988
๐
Springer
๐
English
โ 400 KB
Introduction of plasma indomethacin leve
โ
H. W. Seyberth; G. Knapp; D. Wolf; H. E. Ulmer
๐
Article
๐
1983
๐
Springer
๐
English
โ 676 KB
First results are described of individually tailored indomethacin dose rates employing on-line drug level monitoring for pharmacologically induced ductal constriction in very low birth weight infants with symptomatic patent ductus arteriosus (sPDA). In addition prolonged indomethacin therapy was int